Somatostatin Acetate

Somatostatin Acetate Alias :15-28-Somatostatin-28, Synthetic cyclic growth hormone release-inhibiting factor, Synthetic somatostatin-14 Cas No. : 38916-34-6 Molecular Formula : C76H104N18O19S2 Molecular Weight : 1637.88 MS :

Purity (HPLC) : 98.0%min.

Appearance : White powder Single Impurity (HPLC) : 1.0%max Amino Acid Composition : ±10% of theoretical Peptide Content (N%) : ≥80.0% Water Content (Karl Fischer) : ≤8.0% Acetate Content (HPIC) : ≤15.0% MS (ESI) : Consistent Specific Rotation (20/D) : -37.0～-47.0°(c=1 1%HAc) Mass Balance : 95.0~105.0% Grade : Pharmaceutical Grade Storage: Closed, below 2 ~ 8℃ preservation Manufacturer : NJBN STEROIDS Usage : Somatostatin regulates insulin and glucagon, and regulates the endocrine system and affects neurotransmission and cell proliferation.

2.Description : Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) or somatotropin release-inhibiting hormone is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones.

Somatostatin regulates insulin and glucagon. Somatostatin has two active forms produced by alternative cleavage of a single preproprotein: one of 14 amino acids, the other of 28 amino acids. In all vertebrates, there exist six different somatostatin genes that have been named SS1, SS2, SS3, SS4, SS5, and SS6.

The six different genes along with the five different somatostatin receptors allows somatostatin to possess a large range of functions. Humans have only one somatostatin gene, SST.